Mutant ubiquitin (UBB+1) associated with neurodegenerative disorders is hydrolyzed by ubiquitin C-terminal hydrolase L3 (UCH-L3) (Q24314548)

protein catabolic process

GOA release 2020-03-11

1 reference

Ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Nico P Dantuma

6

0 references

Harry W M Steinbusch

5

object named as

Harry W M Steinbusch

0 references

author name string

Frank J A Dennissen

1

0 references

Natalia Kholod

2

0 references

Denise J H P Hermes

3

0 references

Nadja Kemmerling

4

0 references

Fred W van Leeuwen

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

7

0 references

language of work or name

English

0 references

publication date

19 August 2011

0 references

published in

FEBS Letters

0 references

volume

585

0 references

issue

16

0 references

page(s)

2568-74

0 references

1 reference

A genomic and functional inventory of deubiquitinating enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Structural Insights into the Assembly and Function of the SAGA Deubiquitinating Module

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

UBE3A/E6-AP mutations cause Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Structural basis for the specificity of ubiquitin C-terminal hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

1 reference

7 January 2021

Microtiter plate transformation using the LiAc/SS carrier DNA/PEG method

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

7 January 2021

Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

7 January 2021

DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.06.037

7 January 2021